Today: 14 July 2026
Space Stocks Week Ahead: Can SpaceX’s Nasdaq-100 Entry Reverse the Selloff?

Space Stocks Week Ahead: Can SpaceX’s Nasdaq-100 Entry Reverse the Selloff?

NEW YORK, July 12, 2026, 16:34 EDT

No, not on its own. Space Exploration Technologies ’s rapid entry into the Nasdaq-100 has not produced a broad lift for space shares. SpaceX fell 10.3% from July 2 through Friday even though its inclusion was expected to generate about $4.3 billion of passive buying — automatic purchases by funds tracking the index. An equal-weight basket, giving each stock the same influence, of Rocket Lab , AST SpaceMobile and Planet Labs slid 16.7%. The split suggests validation is concentrating capital in the leader, not widening appetite for smaller space stocks.

The scale mismatch is more revealing than the direction. The estimated SpaceX flow equals 8.8% of Rocket Lab’s Friday market value, 20.2% of AST SpaceMobile’s and 47.8% of Planet’s. Yet only SpaceX receives that index-linked demand. Blue Origin’s reported target pre-money valuation — its value before new cash enters — was $130 billion, about 64% above the three listed peers’ combined $79.4 billion. Private-market benchmarks rose while public investors paid less for adjacent exposure.

CompanyJuly 2 closeJuly 10 closeWeekly moveFriday market value
SpaceX$162.00$145.30-10.3%$1.91 trillion
Rocket Lab$100.46$81.04-19.3%$49.1 billion
AST SpaceMobile$85.13$73.32-13.9%$21.3 billion
Planet Labs$31.38$26.05-17.0%$9.0 billion

Weekly changes are calculated from July 2 and July 10 closing prices; figures are rounded.

Rocket Lab supplied the clearest evidence of why the distinction matters now. On July 7, the company said its VICTUS HAZE mission for the U.S. Space Force launched 16 hours and 42 minutes after receiving notice, commissioned its spacecraft within 38 hours and completed rendezvous-and-proximity operations in less than 59 hours. Each milestone beat the programme’s deadline. The shares still lost 10.4% that day and 19.3% over the week, indicating that technical execution alone was not enough to command a higher valuation.

Planet produced a similar signal. Its Pelican-11 technology demonstrator reached orbit and established initial contact, advancing a satellite platform designed eventually to provide imagery at resolutions of up to 30 centimetres. Crucially for investors, Planet said Pelican-11 was not expected to produce commercially available data. The stock fell 7.1% on the launch day and 17% for the week. A demonstrator can reduce engineering risk without changing near-term sales.

Together, the two missions show why launch success and stock performance have diverged. Last week’s market appeared to rank milestones by proximity to cash generation: index-backed demand and recurring services were valued more highly than engineering proof. The key screen for the coming week is therefore monetization risk — the possibility that working hardware does not translate quickly into repeatable revenue.

Macroeconomic data could overwhelm company news. The Bureau of Labor Statistics releases June consumer-price data on Tuesday and producer-price data on Wednesday, both at 8:30 a.m. EDT. Hotter inflation can lift Treasury yields; higher yields reduce the present value of profits expected far in the future. That dynamic tends to matter most for capital-intensive companies still funding satellite networks, new rockets or manufacturing capacity.

Rocket Lab has the week’s clearest company-level test. NASA lists its LOXSAT mission for no earlier than July 17, using Rocket Lab’s Electron launch vehicle and Photon spacecraft for a nine-month demonstration of 11 cryogenic fluid-management technologies. Because Rocket Lab is supplying the launch, spacecraft and operations, the mission tests its integrated business model rather than a single launch service. A clean result would reinforce execution credentials; a postponement would delay that read-through.

Before then, investors should watch whether SpaceX stabilizes now that index-linked buyers have entered. A continued fall despite expected automatic demand would suggest the new flow supplied liquidity to sellers rather than a durable price floor. For the smaller names, relative performance matters more than a one-day launch bounce: even a flat week would be notable if SpaceX weakens and the peer basket stops losing ground.

Risks: Softer inflation, a major defence award or a successful LOXSAT mission could trigger a sharp rebound after last week’s double-digit declines. Launch delays, mission failures, fresh equity issuance or higher yields could deepen the losses. The comparison also overlooks differences in public float, business mix and capital requirements, while Blue Origin’s valuation remains a reported fundraising target rather than a completed transaction.

The bottom line is that SpaceX’s index debut validated space as a mainstream investment category but also exposed its capacity to absorb capital that might otherwise reach smaller companies. Until technical milestones translate more visibly into contracted, recurring revenue, the SpaceX halo is more likely to remain narrow than lift the entire sector.

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

Stock Market Today

  • AMD Drops 4.21% on Heavy Volumes, Mixed Technicals Keep Traders Cautious
    July 13, 2026, 9:16 PM EDT. Advanced Micro Devices (AMD) slid 4.21% to $534.39 on July 13, 2026, swinging 4.73% intraday. The stock's up 2.46% over the past two weeks, but bigger volume as shares fell is giving traders pause. Analysts see an 85.20% upside for AMD over the next three months, with shares moving between $984.16 and $1,144.95. But the technical picture is mixed-short-term moving averages suggest a sell while the long-term view is still a buy. Recent negative pivot points look bearish in the near term. There's support at $521.58, which some see as a possible entry. Volatility is high and risk is moderate, so the action needs watching.
Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector’s 9% Earnings Drop
Previous Story

Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector’s 9% Earnings Drop

Energy Stocks Week Ahead: Can U.S. Refiners Keep Beating the Oil Sector?
Next Story

Energy Stocks Week Ahead: Can U.S. Refiners Keep Beating the Oil Sector?

Go toTop